Advanced Human Imaging (ASX:AHI) - Chairman & CEO Vlado Bosanac
Chairman & CEO Vlado Bosanac
Source: AHI
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Advanced Human Imaging (AHI) has signed a marketing agreement with Tinjoy Biotech ahead of the launch of the two companies’ combined product
  • AHI’s BodyScan and FaceScan technology will be integrated into Tinjoy’s WinScan offering in China by July this year
  • The ASX-lister’s CompleteScan technology will eventually be integrated into WinScan as well, with extensive promotion planned ahead of the launch
  • Advanced Human Imaging has announced today it’ll hand US$200,000 (around A$258,000) to Tinjoy to help the planned promotion
  • This specific promotion is designed to help Tinjoy reach an initial one million monthly active users as part of its overall agreement with AHI
  • Shares in Advanced Human Imaging have opened the week down 2.51 per cent at $1.75 per share

Advanced Human Imaging (AHI) has signed a marketing agreement with Tinjoy Biotech ahead of the launch of the companies’ combined product.

The two businesses signed an agreement in February this year to integrate AHI’s BodyScan and FaceScan technology into Tinjoy’s WinScan offering.

At this stage, AHI and Tinjoy’s integrated product is on track to launch in July, while the ASX-lister’s CompleteScan technology will eventually be integrated into WinScan as well.

Ahead of that final integration, a marketing strategy has been implemented with 500 call centre team members being trained in demonstrating the functionality of the integrated WinScan offering.

Meanwhile, Advanced Human Imaging has announced today it’ll hand over US$200,000 (around A$258,000) in three tranches to Tinjoy to help this planned promotion of the integrated product.

This specific promotion is also designed to help Tinjoy work towards hitting the agreed target of an initial one million monthly active users as part of its overall agreement with AHI.

Tinjoy currently services around 28 million monthly consumers both digitally and in person in China with its various health offerings.

“We will be offering the CompleteScan experience to all of our customers as a
way to have them monitor their personal health and then communicate this back to our teams to deliver better more understandable care,” Tinjoy Executive Director Russell Bateman said.

“We are excited to work with Advanced Human Imaging and to bring this comprehensive and innovative digital health evaluation platform to WinScan and the enormity of the China market,” he added.

Advanced Human Imaging Chairman and CEO Vlado Bosanac said the integration with WinScan was progressing well.

“Our teams have been in constant communications over the last 8 weeks progressing the application integration points,” the AHI CEO said.

“The production is moving well, and Russell has been a major driver on the Tinjoy side, making sure communication flows and we meet our target release date,” he added.

Shares in Advanced Human Imaging have opened this week’s trading session down a slight 2.51 per cent at $1.75 per share.

AHI by the numbers
More From The Market Online

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported…

PYC Therapeutics takes Polycystic Kidney Disease drug to human trials

PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts…